|
| 2017, Vol. 16(5): 470-479 DOI: 10.1016/S1499-3872(17)60044-4 | ||
| Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antivirals | ||
| Yan Huang, Ming-Hui Li, Min Hou and Yao Xie | ||
| Beijing, China Author Affiliations: Shanghai Roche Pharmaceuticals Ltd., Shanghai 201203, China (Huang Y and Hou M); Liver Disease Center, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China (Li MH and Xie Y) Corresponding Author: Yao Xie, MD, Liver Disease Center, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China (Tel: +86-10-84322284; Email: xieyao00120184@sina.com) |
||
| Received null Revised null | ||
| Supporting info | ||
|